Clinical Nutrition Market Intelligence: Size, Share and Growth Outlook Through 2036
By Product, Application, Route, Consumer, and Distribution — Global Forecast to 2036
By Brevintel Editor•June 2026•PDF + Excel
Market Size (2025)
USD 15.6 billion
Market Forecast (2036)
USD 36.0 billion
CAGR (2025-2036)
7.9%
The clinical nutrition market was valued at USD 15.6 billion in 2025. The market is set to reach USD 16.8 billion by 2026-end and grow at a CAGR of 7.9% between 2026-2036 to reach USD 36.0 billion by 2036. Infant Nutrition will dominate with a 46.0% share, while Cancer will lead with a 26.0% share. Oral nutrition accounts for 41.0% of route of administration, pharmacies and drug stores 38.0% of distribution, and pediatric consumers 57.0% of the consumer segment. The USA is poised for growth at 8.2% CAGR through 2036, and South Korea at 8.1%. Competition centers on Abbott Laboratories, Nestle Health Science, and Danone S.A. (Nutricia).
Key Market Trends & Insights
The clinical nutrition market was valued at USD 15.6 billion in 2025 and is set to reach USD 16.8 billion by 2026-end.
The market is forecast to grow at a CAGR of 7.9% between 2026-2036 to reach USD 36.0 billion by 2036.
Infant Nutrition will dominate with a 46.0% share, while Cancer will lead with a 26.0% share.
Oral nutrition accounts for 41.0% of the route of administration segment; pharmacies and drug stores dominate distribution at 38.0%.
The consumer segment comprises 57.0% pediatric consumers.
The USA is poised for growth at 8.2% CAGR through 2036, and South Korea at 8.1%.
Growth in home-based parenteral and enteral nutrition is expanding consumption beyond hospital settings.
Market Overview
Market Size and Outlook
The clinical nutrition market was valued at USD 15.6 billion in 2025 and is set to reach USD 16.8 billion by 2026-end.
The market is set to grow at a CAGR of 7.9% between 2026-2036 to reach USD 36.0 billion by 2036.
Infant Nutrition will dominate with a 46.0% share, while Cancer will lead with a 26.0% share.
Oral nutrition accounts for 41.0% of the route of administration segment.
Demand and Growth Drivers
Aging populations and chronic disease prevalence are generating sustained demand for clinical nutrition across hospital and community settings.
Infant nutrition requirements for premature, low-birth-weight, and metabolically compromised neonates create a high-value segment where formulation precision and safety are paramount.
Growth in home-based parenteral and enteral nutrition is expanding consumption beyond hospital settings into retail and pharmacy channels.
Capacity expansion in neonatal intensive care units in developing markets is building procurement pipelines for specialized infant nutrition products.
Analyst Perspective
Brevintel analysis indicates companies that combine clinical evidence-supported formulas with hospital formulary inclusion and pharmacy distribution are better placed as nutritional intervention is recognized as economically efficient care.
Abbott Laboratories, Nestle Health Science, and Danone maintain leadership with broad portfolios and established pharmacy and institutional channels.
Market Dynamics
Drivers, Restraints, and Opportunities
Demand is growing as healthcare systems incorporate nutritional support into disease management, recovery, and specialized care protocols.
26.0% of application demand is for cancer, where oncology nutrition products assist patients with treatment-induced malnutrition, weight loss, and immune compromise.
The fastest growing consumer segment is adult clinical nutrition, driven by aging demographics, chronic disease prevalence, and home-based nutritional support programs.
Segmentation Analysis
Product and Application Outlook
Infant nutrition is expected to account for 46.0% of the product segment in 2026, reflecting specialized formulas, human milk fortifiers, and metabolic disorder-specific products.
Cancer will lead application demand with a 26.0% share.
Oral nutrition accounts for 41.0% of the route of administration segment, followed by tube feeding and intravenous nutrition.
Consumer and Channel Outlook
The consumer segment comprises 57.0% pediatric consumers with infant, toddler, and childhood clinical nutrition needs.
Pharmacies and drug stores dominate the distribution segment with 38.0% as the major retail outlet for outpatient clinical nutrition.
Regional Outlook
United States and South Korea
The USA is poised for growth at 8.2% CAGR through 2036, led by CMS reimbursement, NICU network size, and the growing home nutrition support market.
South Korea at 8.1% is attributed to healthcare system investment, MFDS regulatory pathways for medical nutrition products, and aging-population demand.
Competitive Landscape
Overview
Abbott Laboratories, Nestle Health Science, and Danone S.A. (Nutricia) maintain leadership with hospital formulary inclusion and pharmacy and institutional distribution.
Baxter International Inc. and Fresenius Kabi compete in parenteral and hospital nutrition programs.
Buyers compare clinical evidence, safety, and channel coverage when awarding formulary and home-nutrition contracts.
Key Players
Integrated Producers
Abbott Laboratories
Nestle Health Science
Danone S.A. (Nutricia)
Baxter International Inc.
Fresenius Kabi
Specialty Suppliers
Kate Farms
Functional Formularies
Real Food Blends
Meiji Nutrition Care
Nutricia North America
Key Companies Covered
Abbott Laboratories
Nestle Health Science
Danone S.A. (Nutricia)
Baxter International Inc.
Fresenius Kabi
Kate Farms
Functional Formularies
Real Food Blends
Meiji Nutrition Care
Nutricia North America
Table of Contents
The complete report includes additional chapters, data tables, and company profiles beyond this preview.
Key Takeaways
Market Size and CAGR
Top Growth Driver
Fastest Growing Segment
Leading Region
Key Companies
Emerging Opportunities
Executive Summary
Global Market Outlook
Demand-side Trends
Supply-side Trends
Technology Roadmap Analysis
Analysis and Recommendations
Analyst Perspective (What is happening? Why now? What should investors know?)
